Your session is about to expire
← Back to Search
Clinical Surveillance Tool for End of Life Care (HOMR Trial)
N/A
Waitlist Available
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-3 months pre-intervention implementation and 1 month post study completion (at 10 months)
Awards & highlights
HOMR Trial Summary
This trial is testing a tool to help clinicians more reliably identify patients who are approaching the end of life, so that they can better address the patients' unmet needs.
Who is the study for?
This trial is for newly admitted patients to certain medical units who may be in their final year of life. Participants must be able to understand and speak English well enough to answer assessment questions.Check my eligibility
What is being tested?
The trial tests a clinical surveillance tool designed to identify hospital patients at high risk of dying within the next year, aiming to improve palliative care by recognizing unmet needs early.See study design
What are the potential side effects?
Since this study involves a screening tool rather than medication, there are no direct side effects like those associated with drugs. However, emotional or psychological impacts from discussing end-of-life care could occur.
HOMR Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month post study completion (at 10 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month post study completion (at 10 months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Identification and documentation of unmet palliative needs
Secondary outcome measures
Acceptability - Qualitative perception of the implementation team that the application is agreeable, palatable, or satisfactory: The Hexagon Tool
Adoption: the intention, initial decision, or action to employ the application
Appropriateness - implementation team and staff perceived fit, relevance, or compatibility of the application for a given setting
+11 moreFind a Location
Who is running the clinical trial?
Centre for Aging and Brain Health InnovationOTHER
15 Previous Clinical Trials
1,664 Total Patients Enrolled
Bruyere Research InstituteOTHER
34 Previous Clinical Trials
2,020,683 Total Patients Enrolled
2 Trials studying Palliative Care
638 Patients Enrolled for Palliative Care
Unity Health TorontoOTHER
539 Previous Clinical Trials
444,229 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can speak and understand English well enough to answer health questions.I am a new patient in a specific unit during the study period.I cannot complete certain health questionnaires due to cognitive issues or language barriers.This criterion does not apply to me.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research endeavor still have open slots?
"Per clinicaltrials.gov, this medical trial is no longer recruiting patients; the study was initially posted on June 17th 2019 and last updated on May 19th 2021. Nevertheless, there are 22 alternate studies that are still actively enrolling participants."
Answered by AI
At what geographical points is this research project being conducted?
"The list of participating medical centres includes Kingston Health Sciences Centre, Windsor Regional Hospital, and William Osler Health System in Brampton, plus 10 other facilities."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger